Eager to dispel doubts about the difficulties of executing Pfizer Inc.'s $68 billion tie-up with Wyeth, Pfizer's CEO said it will be done more like microsurgery than just stitching two huge corporations together.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer CEO: Wyeth Acquisition Will Avoid Mistakes of Past
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account